
VALID Act Sample Letter to Congress
Participate in this letter writing campaign to further ongoing advocacy efforts to improve and advance The VALID Act, comprehensive diagnostics regulatory reform legislation.
Participate in this letter writing campaign to further ongoing advocacy efforts to improve and advance The VALID Act, comprehensive diagnostics regulatory reform legislation.
AdvaMedDx® hosted an all-member educational session on the diagnostics regulatory reform bill, The VALID Act of 2021.
AdvaMedDx® wrote to affirm our commitment to make modernization of the regulatory framework for IVCTs a reality.
AdvaMedDx® has prepared a high-level FAQ document that addresses key questions you may receive about the bill.
AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge…
The VALID Act marks a milestone in AdvaMedDx® efforts to secure a diagnostic-specific, risk-based and modernized for innovation, regulation of all diagnostic tests – LDTs and IVDs.
AdvaMedDx® supports the modernization of the regulatory framework for all clinical diagnostic tests to foster innovation, embrace scientific advances, and ensure swift access to accurate and reliable tests for all…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement: “AdvaMed® fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle…
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker released the following statement:
AdvaMedDx® developed the VALID Assessment Framework as a tool to analyze the legislation.